DE3248043A1 - Fluorogenic phosphoric esters, process for their preparation, and process and composition for the detection and fluorometric determination of phosphates - Google Patents
Fluorogenic phosphoric esters, process for their preparation, and process and composition for the detection and fluorometric determination of phosphatesInfo
- Publication number
- DE3248043A1 DE3248043A1 DE19823248043 DE3248043A DE3248043A1 DE 3248043 A1 DE3248043 A1 DE 3248043A1 DE 19823248043 DE19823248043 DE 19823248043 DE 3248043 A DE3248043 A DE 3248043A DE 3248043 A1 DE3248043 A1 DE 3248043A1
- Authority
- DE
- Germany
- Prior art keywords
- phenyl
- optionally
- substituted
- phosphorus
- alkoxycarbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 16
- 238000001514 detection method Methods 0.000 title claims description 10
- 239000000203 mixture Substances 0.000 title claims description 7
- 238000002360 preparation method Methods 0.000 title claims description 3
- 150000002148 esters Chemical class 0.000 title abstract description 5
- 229910019142 PO4 Inorganic materials 0.000 title description 2
- 235000021317 phosphate Nutrition 0.000 title description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 title 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims abstract description 20
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims abstract description 20
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims abstract description 4
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims abstract description 4
- -1 C1-C4-alkoxycarbonyl Chemical group 0.000 claims description 50
- 150000001875 compounds Chemical class 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 13
- 150000003014 phosphoric acid esters Chemical class 0.000 claims description 13
- 239000000460 chlorine Substances 0.000 claims description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 10
- 229910052801 chlorine Inorganic materials 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 9
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 6
- 150000002431 hydrogen Chemical group 0.000 claims description 6
- 239000011574 phosphorus Substances 0.000 claims description 6
- 229910052698 phosphorus Inorganic materials 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 6
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 5
- 150000004820 halides Chemical class 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 5
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 4
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 claims description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 3
- 239000002516 radical scavenger Substances 0.000 claims description 3
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 claims description 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 claims description 2
- HOZUBBFWRQFOCK-UHFFFAOYSA-N O=P.Br.Br.Br Chemical compound O=P.Br.Br.Br HOZUBBFWRQFOCK-UHFFFAOYSA-N 0.000 claims description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 2
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 239000012876 carrier material Substances 0.000 claims description 2
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 150000002440 hydroxy compounds Chemical class 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 239000000395 magnesium oxide Substances 0.000 claims description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 125000000542 sulfonic acid group Chemical group 0.000 claims description 2
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 claims description 2
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 150000001450 anions Chemical class 0.000 abstract description 5
- 230000002378 acidificating effect Effects 0.000 abstract description 3
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical class C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 abstract description 2
- 108010051457 Acid Phosphatase Proteins 0.000 description 10
- 102000013563 Acid Phosphatase Human genes 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 235000012015 potatoes Nutrition 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- KNKRKFALVUDBJE-UHFFFAOYSA-N 1,2-dichloropropane Chemical compound CC(Cl)CCl KNKRKFALVUDBJE-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 102100035703 Prostatic acid phosphatase Human genes 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- JNKSPNVKERYFKG-UHFFFAOYSA-N bis(2-oxochromen-3-yl) hydrogen phosphate Chemical class C1=CC=C2C(=C1)C=C(C(=O)O2)OP(=O)(O)OC3=CC4=CC=CC=C4OC3=O JNKSPNVKERYFKG-UHFFFAOYSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- NUMVQHABHCWBHI-UHFFFAOYSA-N chembl244949 Chemical compound C1=CC=C2SC(C3=C(C#N)C4=CC=C(C=C4OC3=O)O)=NC2=C1 NUMVQHABHCWBHI-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000007946 flavonol Chemical class 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910001392 phosphorus oxide Inorganic materials 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 201000001514 prostate carcinoma Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N sulfurochloridic acid Chemical compound OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- 230000002381 testicular Effects 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- VSAISIQCTGDGPU-UHFFFAOYSA-N tetraphosphorus hexaoxide Chemical compound O1P(O2)OP3OP1OP2O3 VSAISIQCTGDGPU-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/60—Quinoline or hydrogenated quinoline ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
- C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2334/00—O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
- C12Q2334/20—Coumarin derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Quinoline Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Fluorogene Phosphorsäureester, Verfahren zu deren Her-Fluorogenic phosphoric acid esters, process for their production
stellung sowie Verfahren und Mittel zum Nachweis und zur fluorometrischen Bestimmung von Phosphatasen Die Erfindung betrifft neue fluorogene Phosphorsäureester, die unter dem Einfluß von Phosphatasen ein stark fluoreszierendes farbiges Anion bilden und zu einer verbesserten Bestimmungsmethode für Phosphatasen verwendet werden können.position as well as methods and means for detection and for fluorometric Determination of phosphatases The invention relates to new fluorogenic phosphoric acid esters, which under the influence of phosphatases a strongly fluorescent colored anion and can be used to improve the determination of phosphatases can.
Fluorimetrische Verfahren zur Bestimmung von Phosphatase-Aktivitäten sind bereits seit längerem bekannt (Guilbault, Enzymatic Methods of Analysis, Pergamon Press 1970). Die Fluorimetrie ist so empfindlich, daß hiermit auch äußerst geringe Enzymkonzentrationen nachgewiesen und bestimmt werden können. Bekannte fluorimetrisch verwendete Phosphatase-Reagentien sind Phosphorsäureester des Umbelliferons (G.G.Guilbault et al., Anal. Letters 1 (1968) 333), des 4-Methylumbelliferons (H.N.Fernley, P.G.Walker, Biochem. J. 97 (1965) 95), des Flavonols (D.B.Land, E.Jakim, Anal. Biochem. 16 (1966) 481), des .t-Naphthols (D.W.Moss, Clin. chim.Fluorimetric method for the determination of phosphatase activities have long been known (Guilbault, Enzymatic Methods of Analysis, Pergamon Press 1970). The fluorimetry is so sensitive that it is also extremely slight Enzyme concentrations can be detected and determined. Known fluorometric Phosphatase reagents used are phosphoric acid esters of umbelliferone (G.G.Guilbault et al., Anal. Letters 1 (1968) 333), 4-methylumbelliferone (H.N. Fernley, P.G.Walker, Biochem. J. 97 (1965) 95), of flavonol (D.B. Land, E. Jakim, Anal. Biochem. 16 (1966) 481), des .t-naphthol (D.W. Moss, Clin. Chim.
Acta 5 (1960) 283), des B-Naphthols (L.J.Greenberg, Biochem Biophys. Res. Comm. 9 (1962) 430) und des 3-0-Methyl-fluoresceins (H.D. Hill et al., Anal. Biochem. 24 (1968) 9).Acta 5 (1960) 283), B-naphthol (L.J. Greenberg, Biochem Biophys. Res. Comm. 9 (1962) 430) and 3-0-methyl-fluorescein (H.D. Hill et al., Anal. Biochem. 24 (1968) 9).
Diese bekannten Nachweisverfahren sind jedoch aus verschiedenen Gründen nicht voll befriedigend: Die Phosphorsäureester des genannten Standes der Technik werden nur im alkalischen pH-Bereich rasch genug gespalten, um in der klinischen Analytik verwendet werden zu können. Für die Diagnose, beispielsweise bei der Früherkennung von Prostata-Karzinomen, wäre es jedoch wichtig, auch saure Phosphatase-Aktivitäten zu bestimmen. Bei vielen der-bekannten fluorogenen Phosphorsäureester tritt darüber hinaus eine störende Überlappung der Fluoreszenz des Esters und des bei der Hydrolyse entstehenden Anions auf. Im übrigen verlangen die Reagentien des Standes der Technik zum Teil auch einen erheblichen apparativen Aufwand.However, these known detection methods are for various reasons not completely satisfactory: the phosphoric acid esters of the prior art mentioned are only split rapidly enough in the alkaline pH range to be in clinical Analytics to be used. For diagnosis, for example for early detection However, from prostate carcinoma, it would be important to also have acid phosphatase activities to determine. With many of the-known fluorogenic phosphoric acid ester occurs over it In addition, there is a disruptive overlap between the fluorescence of the ester and that of the hydrolysis resulting anion. Otherwise, the reagents of the prior art require in some cases also a considerable outlay in terms of equipment.
In US 3 772 340 werden Bis-cumarinylphosphate beschrieben, die zur fluorimetrischen Bestimmung von Phosphodiesterasen dienen sollen, wie sie in bakterienhaltigem Urin auftreten. Ein Nachteil dieser Verbindungen ist ihre Schwerlöslichkeit in Wasser, was ihre praktische Anwendbarkeit begrenzt.In US 3 772 340 bis-coumarinyl phosphates are described, which for fluorimetric determination of phosphodiesterases should be used, as they are in bacteria-containing Urine occur. A disadvantage of these compounds is their poor solubility in water, which limits their practical applicability.
Aufgabe der vorliegenden Erfindung ist es, Reagentien für den fluorimetrischen Nachweis von Phosphatasen zur Verfügung zu stellen, welche von den oben erwähnten Nachteilen des Standes der Technik frei sind. Diese Aufgabe wird mittels der erfindungsgemäßen Phosphorsäureester gelöst.The object of the present invention is to provide reagents for the fluorometric Provide detection of phosphatases which of those mentioned above Disadvantages of the prior art are free. This object is achieved by means of the inventive Phosphoric acid ester dissolved.
Gegenstand der Erfindung sind neue Phosphorsäureester der Formel worin M für Wasserstoff, ein Alkali- oder Ammoniumion, das durch 1 - 4, gegebenenfalls eine Hydroxygruppe enthaltende C1-C2-Alkylreste substituiert sein kann, X für -0- oder -NQ-, Q für Wasserstoff, gegebenenfalls durch 1 - 2 OH-Gruppen substituiertes C1-C4-Alkyl oder für C1-C4-Alkoxycarbonyl, R für Wasserstoff, Chlor, Brom, Cyano oder Carbamoyl, A für Cyano, C1-C4-Alkoxycarbonyl, gegebenenfalls durch 1 - 2 C1-C4-Alkylreste substituiertes Carbamoyl oder Sulfamoyl, C1-C4-Alkylsulfonyl, Benzyl- sulfonyl, Phenylsulfonyl, p-Tolylsulfonyl, p-Chlorphenylsulfonyl, Sulfo, Nitro, Phenyl, p-Tolyl, Sulfophenyl oder für einen gegebenenfalls durch 1 - 2 C1 -C4-Alkyl, 1 - 2 Chlor, C1-C4-Alkoxy, Carboxyl, C1 -C4-Alkoxycarbonyl, Cyano, Trifluormethyl, C1-C4-Alkylsulfonyl, Cyclohexyl, Phenyl oder Sulfo substituierten Benzoxazol-2-yl-, Benzthiazol-2-yl-, Thiazol-2-yl-, Benzimidazol-2-yl-, Chinazol-4-on-2-yl-, 5-Phenyl-1,3,4-thiadiazol-2-yl-, 5-Phenyl-1,3,4-oxadiazol-2-yl-, 2- oder 4-Pyridyl-Rest und R1 für Wasserstoff oder eine Sulfonsäuregruppe stehen.The invention relates to new phosphoric acid esters of the formula wherein M represents hydrogen, an alkali metal or ammonium ion which can be substituted by 1-4 C1-C2-alkyl radicals optionally containing a hydroxyl group, X for -0- or -NQ-, Q for hydrogen, optionally by 1-2 OH -C1-C4-alkyl substituted groups or for C1-C4-alkoxycarbonyl, R for hydrogen, chlorine, bromine, cyano or carbamoyl, A for cyano, C1-C4-alkoxycarbonyl, carbamoyl optionally substituted by 1-2 C1-C4-alkyl radicals or sulfamoyl, C1-C4-alkylsulfonyl, benzylsulfonyl, phenylsulfonyl, p-tolylsulfonyl, p-chlorophenylsulfonyl, sulfo, nitro, phenyl, p-tolyl, sulfophenyl or for one optionally with 1 - 2 C1-C4-alkyl, 1 - 2 chlorine, C1-C4-alkoxy, carboxyl, C1-C4-alkoxycarbonyl, cyano, trifluoromethyl, C1-C4-alkylsulfonyl, cyclohexyl, phenyl or sulfo-substituted benzoxazol-2-yl-, benzthiazol-2-yl-, thiazol-2 -yl-, benzimidazol-2-yl-, quinazol-4-on-2-yl-, 5-phenyl-1,3,4-thiadiazol-2-yl-, 5-phenyl-1,3,4-oxadiazole -2-yl, 2- or 4-pyridyl radical and R1 represent hydrogen or a sulfonic acid group.
Bevorzugt sind jene Verbindungen der allgemeinen Formel (I), in welcher A für einen gegebenenfalls durch 1 - 2 C1-C4-Alkyl, 1 - 2 Chlor, C1-C4-Alkoxy, C1-C4 -Alkylsulfonyl, Carboxyl, C1-C4-Alkoxycarbonyl, Cyclohexyl, Phenyl oder Sulfo substituierten Benzoxazol-2-yl-, Benzthiazol-2-yl-, Thiazol-5-yl-, Benzimidazol-2-yl-, Chinazol-4-on-2-yl-, 5-Phenyl-1,3,4-thiadiazol-2-yl- oder 4-Pyridyl-Rest steht.Preferred are those compounds of the general formula (I) in which A for one optionally substituted by 1-2 C1-C4-alkyl, 1-2 chlorine, C1-C4-alkoxy, C1-C4 -Alkylsulfonyl, carboxyl, C1-C4-alkoxycarbonyl, cyclohexyl, phenyl or sulfo-substituted Benzoxazol-2-yl-, benzthiazol-2-yl-, thiazol-5-yl-, benzimidazol-2-yl-, quinazol-4-on-2-yl-, 5-phenyl-1,3,4-thiadiazol-2-yl or 4-pyridyl radical.
Besonders bevorzugt sind diejenigen Verbindungen der Formel (I), worin A für einen gegebenenfalls durch Methyl, Ethyl, Chlor, Methoxy, Ethoxy oder Sulfo substituierten Benzthiazol-2-yl- oder Benzoxazol-2-yl-Rest und R für CN stehen.Particularly preferred are those compounds of the formula (I) in which A for one optionally represented by methyl, ethyl, chlorine, methoxy, ethoxy or sulfo substituted benzthiazol-2-yl or benzoxazol-2-yl radical and R. stand for CN.
Die erfindungsgemäßen Phosphorsäureester der Formel (I) können hergestellt werden, indem man Hydroxy-Verbindungen der Formel worin X, A, R und R1 die obengenannte Bedeutung besitzen, zunächst mit einem Halogenid des 5-wertigen Phosphors (vorzugsweise in Gegenwart eines anorganischen oder organischen Säurefängers) umsetzt und die erhaltene Dihalogenphosphonyloxy-Verbindung anschließend hydrolysiert.The phosphoric esters of the formula (I) according to the invention can be prepared by adding hydroxy compounds of the formula in which X, A, R and R1 have the abovementioned meaning, initially reacted with a halide of pentavalent phosphorus (preferably in the presence of an inorganic or organic acid scavenger) and the dihalophosphonyloxy compound obtained is then hydrolyzed.
Als Halogenide des 5-wertigen Phosphors kommen beispielsweise Phosphoroxidtrichlorid, Phosphoroxidtribromid oder Phosphorpentachlorid in Betracht, wobei das letztgenannte bevorzugt dann eingesetzt wird, wenn das Molekül eine Sulfogruppe enthält (vorübergehende Überführung in das entsprechende Sulfochlorid).Examples of halides of pentavalent phosphorus are phosphorus oxide trichloride, Phosphorus oxide tribromide or phosphorus pentachloride into consideration, the latter is preferably used when the molecule contains a sulfo group (temporary Conversion into the corresponding sulfochloride).
Als Säurefänger eignen sich anorganische und organische Basen, beispielsweise wasserfreies Kalium- oder Natriumcarbonat, Magnesiumoxid, Triethylamin, Kollidin, Picolingemische, Pyridin und Dimethylanilin.Inorganic and organic bases are suitable as acid scavengers, for example anhydrous potassium or sodium carbonate, magnesium oxide, triethylamine, collidine, Picoline mixtures, pyridine and dimethylaniline.
Die Reaktion wird vorzugsweise in Gegenwart eines Lösungs- oder Verdünnungsmittels im Temperaturbereich von -5 bis 1000C, im Falle der Phosphoroxidtrihalogenide Vorzugsweise bei 0 - 300C, im Falle von PCl5 vorzugsweise bei 20 - 900C durchgeführt.The reaction is preferably carried out in the presence of a solvent or diluent in the temperature range from -5 to 1000 ° C., preferably in the case of the phosphorus oxide trihalides carried out at 0-300C, in the case of PCl5 preferably at 20-900C.
Als Lösungs- und Verdünnungsmittel eignen sich unter den Reaktionsbedingungen inerte organische Flüssigkeiten wie Toluol, Chlorbenzol, Dichlorbenzol, Dichlormethan, Chloroform, Tetrachlormethan, Dichlorethan, Dichlorpropan, Trichlorethylen, Acetonitril, Dioxan, Tetrahydrofuran oder eine der obengenannten organischen Basen wie Pyridin.Suitable solvents and diluents under the reaction conditions are inert organic liquids such as toluene, chlorobenzene, dichlorobenzene, dichloromethane, Chloroform, carbon tetrachloride, dichloroethane, dichloropropane, trichlorethylene, acetonitrile, Dioxane, tetrahydrofuran or one of the above-mentioned organic bases such as pyridine.
Um die Reaktion des 5-wertigen Phosphorhalogenids mit 2 Molekülen (II) zu vermeiden, sorgt man während der Reaktion zweckmäßig für einen Überschuß an Phosphorhalogenid dadurch, daß man (II) als letzte Komponente nach und nach zugibt, gegebenenfalls vorgelöst in einem der obengenannten Lösungsmittel.About the reaction of the pentavalent phosphorus halide with 2 molecules To avoid (II), it is advisable to ensure an excess during the reaction of phosphorus halide by gradually adding (II) as the last component, optionally pre-dissolved in one of the abovementioned solvents.
Die Hydrolyse der intermediären Dichlorphosphonyloxy-Verbindungen zu (I) kann z.B. durch vorsichtiges Erwärmen mit Wasser auf etwa 50°C, schonender jedoch bei Temperaturen von 0 - 250C durch Neutralisation mit Alkalihydroxid- oder Alkalicarbonat-Lösung oder wäßrigem Ammoniak durchgeführt werden. Anschließend dampft man die erhaltenen Alkali- oder Ammoniumsalze im Vakuum zur Trockne ein oder gewinnt durch Ansäuern mit einer Mineralsäure wie Schwefelsäure die freie Säure (I mit M=H) durch Abfiltrieren.The hydrolysis of the intermediate dichlorophosphonyloxy compounds to (I) can be done more gently, e.g. by carefully warming up with water to about 50 ° C but at temperatures of 0 - 250C by neutralization with alkali hydroxide or Alkali carbonate solution or aqueous ammonia can be carried out. Then steams the alkali metal or ammonium salts obtained are brought to dryness in vacuo or recovered by acidification with a mineral acid such as sulfuric acid the free acid (I with M = H) by filtering off.
Die vorstehend aufgeführte Methode zur O-Phosphorylierung von (II) stimmt im wesentlichen mit der in Houben-Weyl, Methoden der Organischen Chemie, Band XII/2 (1964) S.The above method for the O-phosphorylation of (II) essentially agrees with that in Houben-Weyl, Methods of Organic Chemistry, Volume XII / 2 (1964) pp.
172 - 177 beschriebenen allgemeinen Methode zur Phosphorylierung von aromatischen Hydroxyverbindungen überein.172-177 described general method for the phosphorylation of aromatic hydroxy compounds.
Die Ausgangsverbindungen der Formel (II) sind bekannt (US-PS 3 521 187 Verbindung 11; DE-OS 27 02 337; DE-OS 30 44 128, DE-OS 21 00 295 und DE-OS 3 229 301) oder nach den dort genannten Methoden herstellbar.The starting compounds of the formula (II) are known (US Pat. No. 3,521 187 compound 11; DE-OS 27 02 337; DE-OS 30 44 128, DE-OS 21 00 295 and DE-OS 3 229 301) or according to the methods mentioned there.
Die neuen Verbindungen der Formel (I) sind wasserlösliche, schwach blau (R=H, Cl, Br) oder grünlich (R=CN, CONH2) fluoreszierende und zumeist nur wenig farbige Substanzen, die im wäßrigen Medium von alkalischer oder saurer Phosphatase zum stark fluoreszierenden, tief gelb bis rot gefärbten mesomeren Anion der Formeln gespalten werden.The new compounds of formula (I) are water-soluble, slightly blue (R = H, Cl, Br) or greenish (R = CN, CONH2) fluorescent and mostly only slightly colored substances, which in the aqueous medium of alkaline or acid phosphatase to strong fluorescent, deep yellow to red colored mesomeric anion of the formulas be split.
Die neuen Phosphatase-Reagentien der Formel (I) eignen sich daher zum direkten Phosphatase-Nachweis in biologischen Materialien. Besonders vorteilhaft können sie zur quantitativen fluorimetrischen Bestimmung der alkalischen oder sauren Phosphatasen in der klinischen Analytik verwendet werden.The new phosphatase reagents of the formula (I) are therefore suitable for direct phosphatase detection in biological materials. Particularly beneficial can you for the quantitative fluorometric determination of the alkaline or acid phosphatases can be used in clinical analysis.
Gegenüber den Phosphatase-Reagentien des Standes der Technik weisen die neuen Phosphorsäureester der Formel (I) wesentliche Vorteile auf: 1. Keinerlei störende überlappung der fluorimetrisch zu verfolgenden, bei der enzymatischen Spaltung von (I) entstehenden, starken Fluoreszenz des Hydroxylats (IIIa - IIIb) mit der schwachen Fluoreszenz des eingesetzten Reagenz (I) (große Stoke'sche Verschiebung).Compared to the prior art phosphatase reagents the new phosphoric acid esters of the formula (I) have significant advantages: 1. None disturbing overlap of the fluorimetrically to be followed in the enzymatic cleavage of (I) resulting, strong fluorescence of the hydroxylate (IIIa - IIIb) with the weak fluorescence of the reagent (I) used (large Stoke's shift).
2. Verwendung einfachster Filterfluorimeter möglich, da weder eine Anregung durch UV-Licht, bei der sich in der Regel die Untergrundfluoreszenz des biologischen Materials störend bemerkbar macht, noch die Anwendung aufwendiger Monochromatoren oder Interferenzfilter, wie sie beim Einsatz von 3-O,Methylfluorescein-phosphat gebraucht werden, erforderlich sind.2. Use of the simplest filter fluorimeter possible, as neither one Excitation by UV light, which usually causes the background fluorescence of the biological material makes disturbing noticeable, nor the use of complex monochromators or interference filters, as they are when using 3-O, methylfluorescein phosphate are needed.
3. Bildung des tief farbigen fluoreszierenden Hydroxylatanions (IIIa - IIIb) überraschenderweise bereits unter schwach sauren Bedingungen (z.B. bei pH 5.2). Hierdurch ist es erstmalig möglich, die Aktivität saurer Phosphatasen fluorimetrisch in kontinuierlicher Messung mit einer so hohen Nachweisempfindlichkeit zu verfolgen, wie sie bisher nur bei zeitaufwendigeren nichtkinetischen Verfahren bekannt ist.3. Formation of the deeply colored fluorescent hydroxylate anion (IIIa - IIIb) surprisingly even under weakly acidic conditions (e.g. at pH 5.2). This makes it possible for the first time to fluorimetrically determine the activity of acid phosphatases to be followed in continuous measurement with such a high detection sensitivity, as previously only known in more time-consuming non-kinetic processes.
Die erfindungsgemäßen Phosphorsäureester können zur Bestimmung der Phosphataseaktivität in den verschiedensten Körperflüssigkeiten (Serum; cerebrospinale Flüssigkeit; Urin) verwendet werden. Es ist jedoch auch möglich, die erfindungsgemäßen Reagentien analog zur Lehre der US-PS 3 772 340 zur Messung der Bakterienkonzentration in Flüssigkeiten (z.B. bakteriell infiziertem Urin) heranzuziehen. Zu diesem Zweck werden zunächst in an sich bekannter Weise (z.B. osmotischer Schock; Sphäroplastenbildung) die bakteriellen Enzyme, darunter auch Phosphatasen, freigesetzt. Aus der mittels der erfindungsgemäßen Verbindungen bestimmten Phosphataseaktivität lassen sich dann Rückschlüsse auf die Zahl der vorhandenen Bakterien ziehen.The phosphoric esters according to the invention can be used to determine the Phosphatase activity in various body fluids (serum; cerebrospinale Liquid; Urine). However, it is also possible to use the inventive Reagents analogous to the teaching of US Pat. No. 3,772,340 for measuring the bacterial concentration to be used in liquids (e.g. bacterially infected urine). To this end are initially in a manner known per se (e.g. osmotic shock; spheroplast formation) the bacterial enzymes, including phosphatases, are released. From the means the phosphatase activity determined by the compounds according to the invention can then be Draw conclusions about the number of bacteria present.
Bei der Bestimmung der Phosphataseaktivität können die erfindungsgemäßen Verbindungen wegen ihrer guten Wasser löslichkeit in Form wäßriger Lösungen, gegebenenfalls auf den gewünschten pH-Wert gepuffert (z.B. ca. 4,5 -7 für saure Phosphatasen; ca. 7 - 10 für alkalische Phosphatasen), eingesetzt werden. Es ist jedoch auch möglich, die neuen Phosphorsäureester in an sich bekannter Weise auf Träger aufzubringen und die Nachweisreaktion in heterogener Phase ablaufen zu lassen.When determining the phosphatase activity, the inventive Compounds because of their good water solubility in the form of aqueous solutions, if appropriate buffered to the desired pH value (e.g. approx. 4.5 -7 for acid phosphatases; approx. 7-10 for alkaline phosphatases). However, it is also possible to apply the new phosphoric acid esters to a carrier in a manner known per se and to allow the detection reaction to proceed in a heterogeneous phase.
Geeignete Trägermaterialien sind z.B. Filterpapier oder auf einem Kunststoff (z.B. Polystyrol) aufgebrachtes, mit einem organischen Bindemittel versehenes Siliziumdioxid. Es lassen sich auf diese Weise Teststreifen herstellen, die nach dem Aufbringen der zu untersuchenden Flüssigkeit zu fluoreszieren beginnen und deren Fluoreszenz mittels der in der klinischen Analytik üb- lichen Fluorimeter gemessen werden kann. Die quantitative Bestimmung der Phosphatase-Aktivität in einer unbekannten Probe ist möglich, wenn man den zeitlichen Verlauf der Fluoreszenz-Intensität in der wäßrigen Lösung bzw.Suitable carrier materials are e.g. filter paper or on a Plastic (e.g. polystyrene) applied with an organic binder Silicon dioxide. In this way, test strips can be produced that are after the application of the liquid to be examined begin to fluoresce and their Fluorescence by means of the common fluorimeter can be measured. The quantitative determination of phosphatase activity in a unknown sample is possible if one looks at the time course of the fluorescence intensity in the aqueous solution or
auf dem Teststreifen mit jenem von Standards mit bekanntem Phosphatasegehalt vergleicht.on the test strip with that of standards with known phosphatase content compares.
Bei den im folgenden beschriebenen Versuchen wurden als Standards folgende Phosphatasepräparate der Firma Sigma Chemical Co. verwendet: a) alkalische Phosphatase (EC 3.1.3.1): Typ I-S (P7640) (aus Rinderhodenmucosa) b) saure Phosphatasen (EC 3.1.3.2): Typ III (P6760) Typ IV-S (P1146) Typ V (P1267) (aus Weizenkeimlingen, Kartoffeln, Milch und Rinderhoden).In the tests described below, the following phosphatase preparations from Sigma Chemical Co. are used: a) alkaline Phosphatase (EC 3.1.3.1): Type I-S (P7640) (from bovine testicular mucosa) b) acid phosphatases (EC 3.1.3.2): Type III (P6760) Type IV-S (P1146) Type V (P1267) (from wheat seedlings, Potatoes, milk and beef testicles).
EC ist die Bezeichnung für den international gültigen Enzymkatalog.EC is the name for the internationally valid enzyme catalog.
Beispiel 1 800 ml trockenes Pyridin werden unter Kühlung und Rühren bei 0 - 50C tropfenweise mit 39 g (23 ml; 0,25 Mol) Phosphoroxidtrichlorid und anschließend bei der gleichen Temperatur innerhalb von ca. 30 Minuten portionsweise mit 80 g (0,25 Mol) 3-Benzthiazolyl-4-cyano-7-hydroxy-cumarin versetzt und 3 h bei 0 - 50C verrührt. Man trägt auf 2 1 Eiswasser aus, tropft unter Rühren 66 g (45 ml; 0,75 Mol) 45 gew.-%ige Natronlauge hinzu, wobei sich ein pH-Wert von ca. 7 einstellt, läßt die Mischung 10 h rühren, dampft sie mit Hilfe eines Rotationsverdampfers bei 400C im Vakuum zur Trockene ein und trocknet den Rückstand weiter bei 400C im Vakuum bis zu Gewichtskonstanz. Der Rückstand (185 gy besteht aus 44 g Kochsalz und 141 g (96 % der Theorie) der Verbindung der Formel Zur Reinigung wird der Rückstand aus Ethanol-Wasser (4:1) umkristallisiert. Man erhält orangefarbene Kristalle vom Schmelzpunkt 3250C (Zers.).Example 1 800 ml of dry pyridine are mixed with 39 g (23 ml; 0.25 mol) of phosphorus oxychloride dropwise with cooling and stirring at 0 ° -50 ° C. and then at the same temperature within about 30 minutes in portions with 80 g (0.25 mol ) 3-Benzthiazolyl-4-cyano-7-hydroxy-coumarin was added and the mixture was stirred at 0 ° -50 ° C. for 3 h. It is poured onto 2 l of ice water, 66 g (45 ml; 0.75 mol) of 45% strength by weight sodium hydroxide solution are added dropwise with stirring, a pH of approx. 7 being established, the mixture is allowed to stir for 10 h, evaporate it to dryness with the help of a rotary evaporator at 400C in vacuo and dry the residue further at 400C in vacuo to constant weight. The residue (185 gy consists of 44 g of sodium chloride and 141 g (96% of theory) of the compound of the formula For purification, the residue is recrystallized from ethanol-water (4: 1). Orange-colored crystals with a melting point of 3250 ° C. (decomp.) Are obtained.
Die Verbindung ist löslich, z.B. in Wasser, Methanol, Dimethylformamid, Dimethylsulfoxid und Ethylenglykolmonomethylether.The compound is soluble, e.g. in water, methanol, dimethylformamide, Dimethyl sulfoxide and ethylene glycol monomethyl ether.
Zur fluorimetrischen Verfolgung der enzymatischen Hydro lyse wählt man Anregungslicht mit einem Maximum bei 510 nm und mißt die Fluoreszenz bei 595 nm. Bei dieser Wellenlänge wird ausschließlich die Fluoreszenz des enzymatisch gespaltenen Substrats erfaßt.Selects for fluorimetric monitoring of enzymatic hydrolysis excitation light with a maximum at 510 nm and the fluorescence measured at 595 nm. At this wavelength, only the fluorescence of the enzymatically cleaved Substrate detected.
In analoger Weise werden unter Verwendung der entsprechenden Ausgangsverbindungen
die folgenden Phosphorsäureester der allgemeinen Formel
hergestellt:
In analoger Weise werden unter Verwendung der entsprechenden Ausgangsverbindungen
die folgenden sulfogrup-
haltigen Phosphorsäureester der allgemeinen
Formel
hergestellt:
Als Eichsubstanz kann saure Phosphatase aus Kartoffeln (Enzym-Katalog-Nr. 3.1.3.2, Typ IV-S), käuflich erhältlich bei Sigma Chemical Co. unter der Nr. P-1146, mit einer Aktivität von 1.9 Enzymeinheiten/mg verwendet werden (definiert ist die Enzymeinheit als diejenige Menge des Enzyms, die 1 ;iMol p-Nitrophenylphosphat pro Minute bei pH 4,8 und 370C hydrolysiert).Acid phosphatase from potatoes (enzyme catalog no. 3.1.3.2, Type IV-S), commercially available from Sigma Chemical Co. under No. P-1146, with an activity of 1.9 enzyme units / mg can be used (defined is the Enzyme unit as that amount of the enzyme which 1; iMol p-nitrophenyl phosphate per Minute at pH 4.8 and 370C).
Claims (10)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823248043 DE3248043A1 (en) | 1982-12-24 | 1982-12-24 | Fluorogenic phosphoric esters, process for their preparation, and process and composition for the detection and fluorometric determination of phosphates |
| US06/561,391 US4659657A (en) | 1982-12-24 | 1983-12-14 | Chromogenic and fluorogenic esters for photometric or fluorimetric determination of phosphatases or sulphatases |
| GB08333740A GB2133007B (en) | 1982-12-24 | 1983-12-19 | Coumarin snd quinolinone derivatives |
| JP58242358A JPS59130284A (en) | 1982-12-24 | 1983-12-23 | Phosphatase or sulfatase colorimetry and colorimeter |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823248043 DE3248043A1 (en) | 1982-12-24 | 1982-12-24 | Fluorogenic phosphoric esters, process for their preparation, and process and composition for the detection and fluorometric determination of phosphates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3248043A1 true DE3248043A1 (en) | 1984-06-28 |
Family
ID=6181782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19823248043 Withdrawn DE3248043A1 (en) | 1982-12-24 | 1982-12-24 | Fluorogenic phosphoric esters, process for their preparation, and process and composition for the detection and fluorometric determination of phosphates |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS59130284A (en) |
| DE (1) | DE3248043A1 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0217371A3 (en) * | 1985-10-01 | 1988-03-02 | Roche Diagnostics GmbH | Phosphates of resorufin derivatives, process for their preparation and their use in the determination of the activity of phosphatases |
| EP0401813A3 (en) * | 1989-06-08 | 1991-10-16 | Advanced Instruments, Inc. | Method and device for the assay of alkaline phosphatase in dairy products |
| US5585247A (en) * | 1989-05-23 | 1996-12-17 | Behringwerke Aktiengesellschaft | Fluorogenic compounds and their use |
| WO1999005521A3 (en) * | 1997-07-23 | 1999-04-08 | Deutsches Krebsforsch | Conjugate for differentiating between healthy and unhealthy tissue |
| WO1999046402A3 (en) * | 1998-03-10 | 1999-11-18 | Abbott Lab | Water-soluble coumarin fluorescent enzyme substrates |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU230787B1 (en) | 2000-09-11 | 2018-05-02 | Novartis Vaccines & Diagnostics Inc | Quinolinone derivatives as tyrosine kinase inhibitors |
| US7825132B2 (en) | 2002-08-23 | 2010-11-02 | Novartis Vaccines And Diagnostics, Inc. | Inhibition of FGFR3 and treatment of multiple myeloma |
| AU2003290699B2 (en) | 2002-11-13 | 2009-08-27 | Novartis Vaccines And Diagnostics, Inc. | Methods of treating cancer and related methods |
| CA2556872C (en) | 2004-02-20 | 2015-05-12 | Chiron Corporation | Modulation of inflammatory and metastatic processes |
| DK1885187T3 (en) | 2005-05-13 | 2013-12-09 | Novartis Ag | Method of Treating Drug-Resistant Cancer |
| MX2007014381A (en) | 2005-05-17 | 2008-02-06 | Novartis Ag | Methods for synthesizing heterocyclic compounds. |
| AU2006249847B2 (en) | 2005-05-23 | 2012-12-20 | Novartis Ag | Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one lactic acid salts |
| WO2018159810A1 (en) * | 2017-03-03 | 2018-09-07 | 国立大学法人東京大学 | Fluorescent probe for detecting alkaline phosphatase, and use for same |
-
1982
- 1982-12-24 DE DE19823248043 patent/DE3248043A1/en not_active Withdrawn
-
1983
- 1983-12-23 JP JP58242358A patent/JPS59130284A/en active Pending
Non-Patent Citations (3)
| Title |
|---|
| C.A. 57, 13729f, 1962 * |
| C.A. 62, 9112f, 1965 * |
| C.A. 64, 2061d, 1966 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0217371A3 (en) * | 1985-10-01 | 1988-03-02 | Roche Diagnostics GmbH | Phosphates of resorufin derivatives, process for their preparation and their use in the determination of the activity of phosphatases |
| JPS6399083A (en) * | 1985-10-01 | 1988-04-30 | ベ−リンガ−・マンハイム・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | Phosphate of resorufine, its production and phosphatase detecting diagnostic agent containing the same |
| US5585247A (en) * | 1989-05-23 | 1996-12-17 | Behringwerke Aktiengesellschaft | Fluorogenic compounds and their use |
| US5648229A (en) * | 1989-05-23 | 1997-07-15 | Behringwerke Aktiengesellschaft | Fluorogenic compounds and their use |
| US5696001A (en) * | 1989-05-23 | 1997-12-09 | Behringwerke Aktiengesellschaft | Fluorogenic compounds and their use |
| EP0401813A3 (en) * | 1989-06-08 | 1991-10-16 | Advanced Instruments, Inc. | Method and device for the assay of alkaline phosphatase in dairy products |
| WO1999005521A3 (en) * | 1997-07-23 | 1999-04-08 | Deutsches Krebsforsch | Conjugate for differentiating between healthy and unhealthy tissue |
| WO1999046402A3 (en) * | 1998-03-10 | 1999-11-18 | Abbott Lab | Water-soluble coumarin fluorescent enzyme substrates |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59130284A (en) | 1984-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4659657A (en) | Chromogenic and fluorogenic esters for photometric or fluorimetric determination of phosphatases or sulphatases | |
| DE3781170T2 (en) | HYDROLYSABLE FLUORESCENT SUBSTRATES AND THEIR USE FOR ANALYTICAL DETERMINATION. | |
| DE69028639T2 (en) | ENZYME-ENHANCED LANTHANIDE CHELATE LUMINESCENCE DETECTION | |
| DE3851265T2 (en) | Hydrolyzable compounds that release electron-transfer agents and their analytical use. | |
| EP0431456B1 (en) | Use of a heavily soluble salt of a heteropolyacid for the determination of an analyte a corresponding assay and means useful therefor | |
| DE3248043A1 (en) | Fluorogenic phosphoric esters, process for their preparation, and process and composition for the detection and fluorometric determination of phosphates | |
| DE2249165C2 (en) | 3-Styryl-ceph-3-em-4-carboxylic acids, process for their preparation and their use | |
| DE68928412T2 (en) | PRODUCTION AND USE OF FLUORESCENT BENZOTHIAZOLE DERIVATIVES | |
| DE69828035T2 (en) | DETECTION OF MICROBIAL METABOLITES | |
| DE69018567T2 (en) | Method for the detection of microorganisms by using resorufin or orcirufin. | |
| DE4311460A1 (en) | Method for the colorimetric determination of an analyte using benzyl alcohol dehydrogenase and a chromogenic redox indicator | |
| DE3586336T2 (en) | COMPOSITIONS CONTAINING TRIARYLMETHANE LEUKO DYES AND ELEMENTS AND METHOD FOR USE THEREOF. | |
| DE19639169A1 (en) | Redox-active compounds and their application | |
| DE3303871A1 (en) | FLUOROGENEOUS PHOSPHORIC ACID ESTERS, METHOD FOR THE PRODUCTION THEREOF AND METHODS FOR DETECTING AND FOR FLUORIMETRIC DETERMINATION OF PHOSPHATASES | |
| DE69533035T2 (en) | Method for producing a chemiluminescence | |
| DE60018758T2 (en) | Chemiluminescent substrate of hydrolases such as phosphatases | |
| DE3413118A1 (en) | ANALYSIS METHOD AND MEANS FOR DETECTING ESTEROLYTIC AND / OR PROTEOLYTIC ENZYMS | |
| EP0137177B1 (en) | Chromogene and fluorogene carboxylic-acid esters, method for their preparation and agents for the detection and determination of hydrolases | |
| EP0247373B1 (en) | 7-(phenylacetamido)-4-alkyl coumarins, process for their preparation as well as their application in processes for the fluorometric determination of the activity of hydrolases, especially of penicilline g acylase | |
| DE69124780T2 (en) | Oxidizable, color-producing reagent | |
| DE69815060T2 (en) | New potentially fluorogenic compounds | |
| DE69010184T2 (en) | Naphthotriazolium salts. | |
| US4879243A (en) | Use of substituted ortho-quinones as electron transfer agents in analytical determinations | |
| DE3783532T2 (en) | COMPOSITION AND METHOD USING SUBSTITUTED ORTHO-CHINONES AS ELECTRON TRANSFER AGENTS IN ANALYTICAL DETERMINATIONS. | |
| EP0217371A2 (en) | Phosphates of resorufin derivatives, process for their preparation and their use in the determination of the activity of phosphatases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8125 | Change of the main classification |
Ipc: C07F 9/553 |
|
| 8130 | Withdrawal |